series-a
Stage
2
Investors
About
ClostraBio is developing next-generation probiotics and advanced metabolite delivery solutions targeting gut health conditions such as inflammatory bowel disease and food allergies.
Explore ClostraBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.